BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37641049)

  • 1. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial.
    Mehran L; Amouzegar A; Foroutan SM; Masoumi S; Tohidi M; Abdi H; Aghaei A; Saghafinia AE; Azizi F
    BMC Endocr Disord; 2023 Aug; 23(1):182. PubMed ID: 37641049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
    Jonklaas J; Burman KD
    Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of Resistance to Exogenous Thyroxine in Humans.
    Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
    Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
    [No Abstract]   [Full Text] [Related]  

  • 6. Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.
    Idrees T; Palmer S; Maciel RMB; Bianco AC
    Thyroid; 2020 Oct; 30(10):1399-1413. PubMed ID: 32279609
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function.
    DiStefano J; Jonklaas J
    Front Endocrinol (Lausanne); 2019; 10():746. PubMed ID: 31803137
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.
    Kaminski J; Miasaki FY; Paz-Filho G; Graf H; Carvalho GA
    Arch Endocrinol Metab; 2016; 60(6):562-572. PubMed ID: 27982198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Hypothyroid Patients With L-Thyroxine (L-T4) Plus Triiodothyronine Sulfate (T3S). A Phase II, Open-Label, Single Center, Parallel Groups Study on Therapeutic Efficacy and Tolerability.
    Santini F; Ceccarini G; Pelosini C; Giannetti M; Ricco I; Querci G; Grossi E; Saponati G; Vitti P
    Front Endocrinol (Lausanne); 2019; 10():826. PubMed ID: 31849843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.
    Paone L; Fleisch AF; Feldman HA; Brown RS; Wassner AJ
    J Pediatr; 2016 Aug; 175():167-172.e1. PubMed ID: 27178621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.
    Yavuz S; Linderman JD; Smith S; Zhao X; Pucino F; Celi FS
    J Clin Endocrinol Metab; 2013 May; 98(5):E862-6. PubMed ID: 23585666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
    Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
    [No Abstract]   [Full Text] [Related]  

  • 14. Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?
    Peterson SJ; McAninch EA; Bianco AC
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4964-4973. PubMed ID: 27700539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism.
    Shakir MKM; Brooks DI; McAninch EA; Fonseca TL; Mai VQ; Bianco AC; Hoang TD
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4400-e4413. PubMed ID: 34185829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Thyroid-Hormone Requirements Consistent With Type 3 Deiodinase Induction Related to Ibrutinib in a Thyroidectomized Woman.
    Mazori AY; Skamagas M
    AACE Clin Case Rep; 2021; 7(2):121-123. PubMed ID: 34095468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients.
    Ettleson MD; Prieto WH; Russo PST; de Sa J; Wan W; Laiteerapong N; Maciel RMB; Bianco AC
    J Clin Endocrinol Metab; 2023 May; 108(6):e258-e266. PubMed ID: 36515655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
    Solter D; Solter M
    Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.